Mutations in Methionyl-Trna Synthetase Gene in a Chinese Family with Interstitial Lung and Liver Disease, Postnatal Growth Failure and Anemia

Yu Sun,Guorui Hu,Jihang Luo,Di Fang,Yongguo Yu,Xiang Wang,Jing Chen,Wenjuan Qiu
DOI: https://doi.org/10.1038/jhg.2017.10
2017-01-01
Journal of Human Genetics
Abstract:Methionyl-tRNA synthetase (MARS) catalyzes the ligation of methionine to tRNA. Heterozygous MARS mutations have been reported to cause Charcot-Marie-Tooth disease, axonal, type 2U (CMT2U). Homozygous or compound heterozygous mutations in MARS gene would cause interstitial lung and liver disease (ILLD), a severe disease onset in infancy or early childhood. Here we report a Chinese ILLD family with two affected boys diagnosed by exome sequencing. They carry novel compound heterozygous MARS mutations (p.Asp145Asn and p.Phe802Ser). Their phenotype is concordant with ILLD description. As ILLD patients were only reported by two studies, we summarized all the reported patients and characterized the principle clinical features as interstitial lung disease, developmental delay, postnatal growth failure, non-life-threatening liver dysfunction and anemia. Genotype–phenotype correlation analysis suggests most of the ILLD mutations locate in the catalytic domain of MARS. ILLD and CMT2U might have different disease mechanism.
What problem does this paper attempt to address?